169 related articles for article (PubMed ID: 9871775)
1. Dimers of 5HT1 ligands preferentially bind to 5HT1B/1D receptor subtypes.
Perez M; Jorand-Lebrun C; Pauwels PJ; Pallard I; Halazy S
Bioorg Med Chem Lett; 1998 Jun; 8(11):1407-12. PubMed ID: 9871775
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist.
Doménech T; Beleta J; Palacios JM
Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):328-34. PubMed ID: 9303569
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
Khawaja X; Ennis C; Minchin MC
Life Sci; 1997; 60(9):653-65. PubMed ID: 9048968
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and serotonergic activity of arylpiperazide derivatives of serotonin: potent agonists for 5-HT1D receptors.
Perez M; Fourrier C; Sigogneau I; Pauwels PJ; Palmier C; John GW; Valentin JP; Halazy S
J Med Chem; 1995 Sep; 38(18):3602-7. PubMed ID: 7658447
[TBL] [Abstract][Full Text] [Related]
5. Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.
Newman-Tancredi A; Verrièle L; Millan MJ
Br J Pharmacol; 2001 Jan; 132(2):518-24. PubMed ID: 11159702
[TBL] [Abstract][Full Text] [Related]
6. Modulation of agonist and antagonist interactions in serotonin 1A receptors by alcohols.
Harikumar KG; Chattopadhyay A
FEBS Lett; 1998 Oct; 438(1-2):96-100. PubMed ID: 9821966
[TBL] [Abstract][Full Text] [Related]
7. Autoradiographic localization of 5HT1 binding sites in autonomic areas of the rat dorsomedial medulla oblongata.
Thor KB; Blitz-Siebert A; Helke CJ
Synapse; 1992 Mar; 10(3):217-27. PubMed ID: 1532678
[TBL] [Abstract][Full Text] [Related]
8. Autoradiographic localization of 5HT1 binding sites in the medulla oblongata of the rat.
Thor KB; Blitz-Siebert A; Helke CJ
Synapse; 1992 Mar; 10(3):185-205. PubMed ID: 1532676
[TBL] [Abstract][Full Text] [Related]
9. Radioligand binding analysis of knockout mice reveals 5-hydroxytryptamine(7) receptor distribution and uncovers 8-hydroxy-2-(di-n-propylamino)tetralin interaction with alpha(2) adrenergic receptors.
Bonaventure P; Nepomuceno D; Hein L; Sutcliffe JG; Lovenberg T; Hedlund PB
Neuroscience; 2004; 124(4):901-11. PubMed ID: 15026130
[TBL] [Abstract][Full Text] [Related]
10. Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice.
Bonaventure P; Nepomuceno D; Kwok A; Chai W; Langlois X; Hen R; Stark K; Carruthers N; Lovenberg TW
J Pharmacol Exp Ther; 2002 Jul; 302(1):240-8. PubMed ID: 12065723
[TBL] [Abstract][Full Text] [Related]
11. Imidazoline-modified benzylimidazolines as h5-HT(1D/1B) serotonergic ligands.
Prisinzano T; Law H; Dukat M; Slassi A; MaClean N; Demchyshyn L; Glennon RA
Bioorg Med Chem; 2001 Mar; 9(3):613-9. PubMed ID: 11310595
[TBL] [Abstract][Full Text] [Related]
12. Detection and characterization of a 5HT1D serotonin receptor-GTP binding protein interaction in porcine and bovine brain.
Herrick-Davis K; Titeler M
Synapse; 1989; 3(4):325-30. PubMed ID: 2525822
[TBL] [Abstract][Full Text] [Related]
13. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Audinot-Bouchez V; Lochon S; Lavielle G; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):682-8. PubMed ID: 9205951
[TBL] [Abstract][Full Text] [Related]
14. Functional characteristics of a series of N4-substituted 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazines as 5-HT1A receptor ligands. Structure-activity relationships.
van Steen BJ; van Wijngaarden I; Ronken E; Soudijn W
Bioorg Med Chem Lett; 1998 Sep; 8(18):2457-62. PubMed ID: 9873561
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes.
Zgombick JM; Schechter LE; Adham N; Kucharewicz SA; Weinshank RL; Branchek TA
Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):226-36. PubMed ID: 8878051
[TBL] [Abstract][Full Text] [Related]
16. Further evidence that the serotonin receptor in the rat stomach fundus is not 5HT1A or 5HT1B.
Cohen ML; Wittenauer LA
Life Sci; 1986 Jan; 38(1):1-5. PubMed ID: 3941588
[TBL] [Abstract][Full Text] [Related]
17. RU24969-induced behavioural syndrome requires activation of both 5HT1A and 5HT1B receptors.
O'Neill MF; Parameswaran T
Psychopharmacology (Berl); 1997 Aug; 132(3):255-60. PubMed ID: 9292625
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo.
Aune TM; Golden HW; McGrath KM
J Immunol; 1994 Jul; 153(2):489-98. PubMed ID: 8021490
[TBL] [Abstract][Full Text] [Related]
19. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM
Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846
[TBL] [Abstract][Full Text] [Related]
20. Functional effects of chronic electroconvulsive shock on serotonergic 5-HT(1A) and 5-HT(1B) receptor activity in rat hippocampus and hypothalamus.
Gur E; Dremencov E; Garcia F; Van de Kar LD; Lerer B; Newman ME
Brain Res; 2002 Oct; 952(1):52-60. PubMed ID: 12363404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
